-
ABOUT US
-
R&D
-
AGORA
-
PR
-
RECRUITMENT
-
CONTACT
AGORA
2026-2029
3H Bio timeline for Business and Anti-Obesity Medicine Development
-2026. May: EC Application and CTN submission
-2027. July: Report of Clinical Phase 1a/b Study in Australia